Expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human gallbladder lesions

European Journal of Cancer

Volumn 36, Issue 2, 2000, Pages 257-263

  Yamamoto, S ^a   Kitadai, Y ^a   Tsuchida, A ^a   Sasaki, T ^a   Matsubara, K ^a   Kajiyama, G ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiogenesis; Gallbladder carcinoma; PD ECGF

Indexed keywords

PLATELET DERIVED ENDOTHELIAL CELL GROWTH FACTOR; THYMIDINE PHOSPHORYLASE;

ANGIOGENESIS; ARTICLE; CANCER INVASION; CANCER STAGING; ENZYME LINKED IMMUNOSORBENT ASSAY; GALLBLADDER CANCER; GALLBLADDER DISEASE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ADENOCARCINOMA; ADENOMA; ENDOTHELIAL GROWTH FACTORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GALLBLADDER NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM PROTEINS; NEOPLASM STAGING; THYMIDINE PHOSPHORYLASE;

EID: 0033955960     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(99)00245-2     Document Type: Article

References (47)

1. Folkman J. How is blood vessel growth regulated in normal and neoplastic tissue? G. H. A. Clowes Memorial Award Lecture. Cancer Res 1986, 46, 467-473.
2. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Nail Cancer Inst 1990, 82, 4-6.
3. Weidner N, Folkman J, Pozza F, et al. Tumor angiogenesis: a new significant and independent prognostic indicator in earlystage breast cancer. J Nat! Cancer Inst 1992, 84, 1875-1887.
4. Weidner N. Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol 1995, 147, 9-19.
5. Graham CH, Rivers J, Kerbel RS, Stankiewicz KS, White WL. Extent of vascularization as a prognostic indicator in thin ( < 0.76 mm) malignant melanomas. Am J Pathol 1994, 145, 510-514.
6. Tanigawa N, Amaya H, Matsumura M, et al. Extent of tumor vascularization correlates with prognosis and hematogenous metastasis in gastric carcinomas. Cancer Res 1996, 56, 2671-2676.
7. Yamamoto S, Fujii K, Kitadai Y, Yamamoto So, Tsuchida A, Kajiyama G. Expression of vascular endothelial growth factor in human gallbladder lesions. Oncol Rep 1998, 5, 1065-1069.
8. Bicknell R, Harris AL. Novel growth regulatory factors and tumour angiogenesis. Eur J Cancer 1991, 27A, 781-784.
9. Leung DW, Cachianes G, Kuang W-J, Goeddel DV, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989, 246, 1306-1309.
10. Schluze-Othoff K, Fruhbeis B, Overwien B, Hilbig B, Sorg C. Purification and characterization of a novel human angiogenic factor (h-AF). Biochem Biophys Res Commun 1987, 146, 945-952.
11. Van Hinsbergh VWM, Kooistra T, Emeris JJ, Koolwijk P. Regulation of plasminogen activator production by endothelial role in fibrinolysis and local proteolysis. Int J Radial 1991, 60, 261-272.
12. Höckel M, Sasse J, Wisseier JH. Purified monocyte-derived angiogenic substance (angiotropin) stimulates migration, phenotyping changes, and "tube formation" but not proliferation of capillary endothelial cells in vivo. J Cell Physiol 1987, 133, 1-13.
13. Haraguchi M, Miyadera K, Sumizawa T. Angiogenic activity of thymidine phosphorylase and PD-ECGF. Proc Am Assoc Cancer Res 1993, 53, 5680-5682.
14. Toi M, Hoshina S, Taniguchi T, Yamamoto Y, Ishitsuka H, Tominaga T. Expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast cancer. Int J Cancer 1995, 64, 79-82.
15. Moghaddam A, Zhang H-T, Fan TPD, et al. Thymidine phosphorylase is angiogenic and promotes tumor growth. Proc Natl Acad Sei USA 1995, 92, 998-1002.
16. Finnis C, Dodsworth N, Pollit CE, Carr G, Sleep D. Thymidine phosphorylase activity of platelet derived endothelial cell mitogenicity. Eur J Biochem 1993, 212, 201-210.
17. Ishikawa F, Miyazono K, Hellman U, et al. Identification of angiogenic activity and the cloning and expression of plateletderived endothelial cell growth factor. Nature 1989, 338, 557-562.
18. Takahashi H, Uchino J, Ogita M, et al. Pyrimidine nucleoside phosphorylase activity and biological characteristics of breast cancer. Int J Oncol 1995, 7, 1139-1144.
19. Miyadera K, Dohmae N, Takio K, et al. Structural characterization of thymidine phosphorylase purified from human placenta. Biochem Biophys Res Commun 1995, 212, 1040-1045.
20. Griffiths L, Straford IJ. Platelet-derived endothelial cell growth factor thymidine phosphorylase in tumor growth and response to therapy. Br J Cancer 1997, 76, 689-693.
21. Fox SB, Westwood M, Moghaddam A, et al. The angiogenic factor platelet-derived endothelial cell growth factor/thymidine phosphorylase is up-regulated in breast cancer epithelium and endothelium. Br J Cancer 1996, 73, 275-280.
22. Tanigawa N, Amaya H, Matsumura M, et al. Tumor angiogenesis and expression of thymidine phosphorylase/platelet derived endothelial cell growth factor in human gastric carcinoma. Cancer Lett 1996, 108, 281-290.
23. Takebayashi Y, Miyadera K, Akiyama S, et al. Expression of thymidine phosphorylase in human gastric carcinoma. Jpn J Cancer Res 1996, 87, 288-295.
24. Takebayashi Y, Akiyama S, Akiba S, et al. Clinicopathologic and prognostic significance of an angiogenic factor, thymidine phosphorylase, in human colorectal carcinoma. J Natl Cancer Inst 1996,88, 1110-1117.
25. Koukourakis MI, Giatromanolaki A, O'Byrne KJ, et al. Plateletderived endothelial cell growth factor expression correlates with tumor angiogenesis and prognosis in non-small-cell lung cancer. Br J Cancer 1997, 75, 477-481.
26. Albores-Saavedra J, Henson DE, Sobin LH. Histological Typing of Tumors of the Gallbladder and Extrahepatic Bile Ducts. 2nd edn. Berlin, Springer WHO International Organization International Histological Classification of Tumors, 1991.
27. Sobin LH, Wittekind Ch. U ICC TNM Classification of Malignant Tumors. 5th edn. Tokyo, Kanehara Ltd, 1997.
28. Martinez PL, Platt N, McKnight AJ, DaSilva RP, Gordon S. Macrophage membrane molecules: markers of tissue differentiation and heterogeneity. Immunobiology 1996, 195, 407-416.
29. Fujii K, Yasui W, Kuniyasu H, et al. Expression of cripto in human gallbladder lesions. J Pathol 1996, 180, 166-168.
30. Nobuhiko T, Hirokazu A, Masayuki I, et al. Extent of tumor vascularization correlates with prognosis and hematogenous metastasis in gastric carcinomas. Cancer Res 1996, 56, 2671-2676.
31. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis correlation in invasive breast carcinoma. N EnglJ Med 1991, 324, 1-8.
32. Nishida M, Hino A, Mori K, Matsumoto T, Yoshikubo T, Ishitsuka H. Preparation of anti-human thymidine phosphorylase monoclonal antibodies useful for detecting the enzyme levels in tumor tissues. Bio! Pharm Bull 1996, 19, 1407-1411.
33. Liotta LA, Kleinerman J, Saidel G. The significance of hematogenous tumor cell clumps in the metastatic process. Cancer Res 1976, 36, 889-894.
34. Nagy JA, Brown LF, Senger DR, et al. Pathogenesis of tumor stroma generation: a critical role for leaky blood vessels and fibrin deposition. Biochem Biophys Ada 1988, 948, 305-326.
35. Haraguchi M, Miyadera K, Uemura K, et al. Angiogenic activity of enzymes. Nature 1994, 368, 198.
36. Kitadai Y, Haruma K, Sumii K, et al. Expression of interleukin-8 correlates with vascularity in human gastric carcinomas. Am J Pathol 1998, 152, 93-100.
37. Takahashi Y, Bucana CD, Liu W, et al. Platelet-derived endothelial cell growth factor in human colon cancer angiogenesis. Role of infiltrating cells. J Natl Cancer Inst 1996, 88, 1146-1151.
38. Takahashi Y, Bucana CD, Akagi Y, et al. Significance of plateletderived endothelial cell growth factor in the angiogenesis of human gastric cancer. Clin Cancer Res 1998, 4, 429-434.
39. Connolly DT, Heuvelman DM, Nelson R, et al. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 1989, 84, 1470-1478.
40. Dvorak HF, Siossat TM, Brown LF, et al. Distribution of vascular permeability factors in tumors: concentration in tumor blood vessels. J Exp Med 1991, 174, 1275-1278.
41. Toi M, Inada K, Hoshino S, Suzuki H, Kondo S, Tominaga T. Vascular endothelial growth factor and platelet-derived endothelial cell growth factor are frequently coexpressed in highly vascularized human breast cancer. Clin Cancer Res 1995, 1, 961-964.
42. Saeki T, Tanada M, Takashima S, et al. Correlation between expression of platelet-derived endothelial growth factor (thymidine phosphorylase) and microvessel density in early-stage human colon carcinomas. Jpn Clin Oncol 1997, 27, 227-230.
43. Imazono Y, Takebayashi Y, Nishiyama K, et al. Correlation between thymidine phosphorylase expression and prognosis in human renal cell carcinoma. J Clin Oncol 1997, 15, 2570-2578.
44. O'Brien T, Cranston D, Fuggle S, Bicknell R, Harris WL. Different angiogenic pathways characterized superficial and invasive bladder cancer. Cancer Res 1995, 55, 510-513.
45. Fujieda S, Sunaga H, Tsuzuki H, Tanaka N, Saito H. Expression of platelet-derived endothelial cell growth factor in oral and oropharyngeal carcinoma. Clin Cancer Res 1998, 4, 1583-1590.
46. Giffiths L, Dachs GU, Bickell R, Harris AL, Stratford IJ. The influence of oxygen tension and pH on the expression of plateletderived endothelial cell growth factor/thymidine phosphorylase in human breast tumor cell growth in vitro and in vivo. Cancer Res 1997, 57, 570-572.
47. Kato Y, Nakayama Y, Umeda M, Miyazaki K. Induction of 103-kDa gelatinase/type IV collagenase by acidic culture conditions in mouse metastatic melanoma cell line. J Biol Chem 1992, 267, 11424-11430.